Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

about

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

Item

http://www.wikidata.org/entity/Q55235361

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

@en

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

@nl

type

Item

label

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

@en

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

@nl

prefLabel

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

@en

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

@nl

P1476

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome.

@en

P2093

Chun-Xue Bai

http://www.w3.org/2001/XMLSchema#string

Jun Yin

http://www.w3.org/2001/XMLSchema#string

P2860

In the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort study

Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis

Mass Spectrometry-based Proteomics in Acute Respiratory Distress Syndrome: A Powerful Modality for Pulmonary Precision Medicine

Acute respiratory distress syndrome: the Berlin Definition

The pathophysiology and treatment of sepsis

Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial.

Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury.

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis.

A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury.

P304

1138-1141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4103/0366-6999.231520

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29722332

http://www.w3.org/2001/XMLSchema#string

P921

acute respiratory distress syndrome

pharmacotherapy

P932

5956763

http://www.w3.org/2001/XMLSchema#string